Randy Cron, M.D., Ph.D., Pediatric Rheumatology, and Winn Chatham, M.D., Rheumatology, have been awarded a grant to study the treatment of Cytokine Storm Syndrome in COVID-19 patients. They will serve as co-PIs on their project titled, “Early Identification and Treatment of Cytokine Storm Syndrome in COVID-19.”

The grant was awarded by the School of Medicine and Hugh Kaul Precision Medicine Institute from COVID-19 research funding. It was one of 14 projects selected to receive funding to study various implications of COVID-19. Over 50 applications were submitted for consideration.

The project is a small clinical trial to compare standard of care to standard of care plus anakinra treatment in COVID-19+ adults at UAB with signs of cytokine storm syndrome. Drs. Cron and Chatham and will use the funding for whole genome sequencing and laboratory explorations as related to cytokine storm syndrome.

Congratulations Dr. Cron!